About this trial
This clinical trial aims to evaluate the effectiveness of a pharmacist-led interactive mobile health intervention (serious game) in adults aged 50 years and older with chronic obstructive pulmonary disease (COPD). The study will test whether the intervention improves health status compared with usual care. Secondary outcomes include inhaler technique, medication adherence, health knowledge, dyspnea, clinical events, healthcare utilization, and costs. Participants in the intervention group will receive pharmacist guidance and use the serious game at home for 2 weeks.
Eligibility criteria
Qualifiers
Adults aged 50 years and older
Diagnosed with chronic obstructive pulmonary disease (COPD) and clinically stable at the time of enrollment
Receiving inhalation therapy
Able to use or access a smartphone
Disqualifiers
Other respiratory diseases (active tuberculosis, lung cancer, asthma, and pneumonia)
Serious comorbidities (renal insufficiency and cardiac failure, terminal illness, life expectancy <6 m)
mental disorders or cognitive dysfunction
auditory, visual, or verbal inability
Trial design
Treatments tested in this trial
- Pharmacist-Led mHealth Serious Game
- Usual Care
Treatment groups
Sponsors and collaborators
Universitas Katolik Widya Mandala Surabaya
Lead sponsor
Taipei Medical University
Collaborator